HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Acquisition of fluoroquinolone resistance leads to increased biofilm formation and pathogenicity in Campylobacter jejuni.

Abstract
The World Health Organization has listed C. jejuni as one of 12 microorganisms on a global priority list for antibiotic resistance due to a rapid increase in strains resistant to fluoroquinolone antibiotics. This fluoroquinolone resistance is conferred through a single point mutation in the QRDR region within the gyrA gene known to be involved in DNA supercoiling. We have previously revealed that changes in DNA supercoilikng play a major role in the regulation of virulence in C. jejuni with relaxation of DNA supercoiling associated with increased attachment to and invasion of human epithelial cells. The aim of this study was to investigate whether fluoroquinolone resistant strains of C. jejuni displayed altered supercoiling associated phenotypes. A panel of fluoroquinolone resistant mutants were derived and shown to have a greater ability to form viable biofilms under aerobic conditions, invade epithelial cells and promote virulence in the Galleria mellonella model of infection. We thus report for the first time that fluoroquinolone resistance in C. jejuni is associated with an increase in virulence and the ability to form viable biofilms in oxygen rich environments. These altered phenotypes likely play a critical role in the continued increase in fluoroquinolone resistance observed for this important pathogen.
AuthorsMatthew V X Whelan, Laura Ardill, Kentaro Koide, Chie Nakajima, Yasuhiko Suzuki, Jeremy C Simpson, Tadhg Ó Cróinín
JournalScientific reports (Sci Rep) Vol. 9 Issue 1 Pg. 18216 (12 03 2019) ISSN: 2045-2322 [Electronic] England
PMID31796849 (Publication Type: Journal Article)
Chemical References
  • DNA, Superhelical
  • Fluoroquinolones
  • DNA Gyrase
Topics
  • Biofilms (growth & development)
  • Campylobacter Infections (drug therapy, microbiology)
  • Campylobacter jejuni (genetics, pathogenicity)
  • DNA Gyrase (genetics, metabolism)
  • DNA, Superhelical (drug effects, metabolism)
  • Drug Resistance, Bacterial (drug effects, genetics)
  • Fluoroquinolones (pharmacology, therapeutic use)
  • HT29 Cells
  • Humans
  • Microbial Sensitivity Tests
  • Point Mutation (drug effects)
  • Virulence (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: